• Go to navigation
  • Go to content
AstraZeneca Pharma Netherlands

Astrazeneca Worldwide

  • AstraZeneca Websites
欢迎来到思瑞康中

Main navigation

  • 主页
  • 疾病知识
  • 学术前沿
  • 资源汇总
    • 处方信息
    • 治疗指南
      • 精神分裂症
      • 双相情感障碍
      • 单相抑郁
      • 广泛性焦虑
      • 其他
    • 常用量表
    • 术语表
    • 医学媒体库
    • 医生继续教育课程
    • 学术论文
    • 医学文献检索
    • 友情链接
  • 联系我们
  • 站点地图
  • PubMed

You are here

  • 主页
  • 资源汇总
  • 治疗指南

  • 中国精神分裂症防治指南(摘要)

  • 来源:卫生部疾病控制司,中国精神障碍防治指南专家委员会
  • Biological Treatment of Schizophrenia, part 2: Long-Term Treatment of Schizophrenia - 2006

  • Organisation: World Federation of Societies of Biological Psychiatry (WFSBP)
  • International clinical practice guidelines for early psychosis - 2005

  • Organisation International Early Psychosis Association Writing Group
  • Guidelines for biological treatment of schizophrenia, part 1: acute treatment of schizophrenia - 2005

  • Organisation World Federation of Societies of Biological Psychiatry
  • Canadian Clinical Practice Guidelines for the Treatment of Schizophrenia - 2005

  • Organisation World Federation of Societies of Biological Psychiatry
  • Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders - 2005

  • Organisation The Royal Australian and New Zealand College of Psychiatrists
  • Practice Guideline for the Treatment of Patients with Schizophrenia - 2004

  • Organisation American Psychiatric Association
  • Using Antipsychotic Agents in Older Patients

  • Organisation Expert Consensus Guideline Series
  • Procedures Manual: Schizophrenia Module - 2003

  • Organisation Texan Medication Algorithm Project
  • Expert consensus panel for optimizing pharmacologic treatment of psychotic disorders - 2003

  • Organisation Expert Consensus Panel

登录



  • 注册
  • 忘记密码

页面服务

  • 打印
  • 收藏本页

法律声明

  • 法律声明
  • 隐私条款
  • 版权